MIAT and cancer: Such a long noncoding RNA, MIAT is firstly extracted as a promising gene for myocardial infarction and later has also been identified as a candidate biomarker and therapeutic target in many malignant tumors due to its regulation in cell antiapoptosis, invasion, metastasis, and proliferation via various mechanisms.7